Does the media prefer DOX or CTSH?

In the previous week, Cognizant Technology Solutions had 12 more articles in the media than Amdocs. MarketBeat recorded 15 mentions for Cognizant Technology Solutions and 3 mentions for Amdocs. Cognizant Technology Solutions' average media sentiment score of 1.13 beat Amdocs' score of 0.97 indicating that Cognizant Technology Solutions is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Amdocs 2 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Cognizant Technology Solutions 10 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable valuation and earnings, DOX or SSNC?

SS&C Technologies has higher revenue and earnings than Amdocs. Amdocs is trading at a lower price-to-earnings ratio than SS&C Technologies, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Amdocs $4.53B 1.41 $564.70M $4.20 14.12 SS&C Technologies $6.27B 2.99 $796.90M $3.48 22.97

Is DOX or SSNC more profitable?

SS&C Technologies has a net margin of 13.16% compared to Amdocs' net margin of 9.75%. SS&C Technologies' return on equity of 21.20% beat Amdocs' return on equity. Company Net Margins Return on Equity Return on Assets Amdocs 9.75% 20.28% 10.94% SS&C Technologies 13.16% 21.20% 7.19%

Does the media favor DOX or SSNC?

In the previous week, SS&C Technologies had 6 more articles in the media than Amdocs. MarketBeat recorded 9 mentions for SS&C Technologies and 3 mentions for Amdocs. Amdocs' average media sentiment score of 0.97 beat SS&C Technologies' score of 0.62 indicating that Amdocs is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Amdocs 2 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SS&C Technologies 3 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable earnings & valuation, DOX or ACN?

Accenture has higher revenue and earnings than Amdocs. Amdocs is trading at a lower price-to-earnings ratio than Accenture, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Amdocs $4.53B 1.41 $564.70M $4.20 14.12 Accenture $69.67B 1.73 $7.68B $12.52 14.45

Is DOX or ACN more profitable?

Accenture has a net margin of 10.66% compared to Amdocs' net margin of 9.75%. Accenture's return on equity of 26.47% beat Amdocs' return on equity. Company Net Margins Return on Equity Return on Assets Amdocs 9.75% 20.28% 10.94% Accenture 10.66% 26.47% 12.89%

Does the media favor DOX or ACN?

In the previous week, Accenture had 32 more articles in the media than Amdocs. MarketBeat recorded 35 mentions for Accenture and 3 mentions for Amdocs. Amdocs' average media sentiment score of 0.97 beat Accenture's score of 0.42 indicating that Amdocs is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Amdocs 2 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Accenture 9 Very Positive mention(s) 7 Positive mention(s) 14 Neutral mention(s) 4 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has higher earnings and valuation, DOX or GIB?

CGI Group has higher revenue and earnings than Amdocs. CGI Group is trading at a lower price-to-earnings ratio than Amdocs, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Amdocs $4.53B 1.41 $564.70M $4.20 14.12 CGI Group $11.38B 1.26 $1.19B $5.83 11.89

Is DOX or GIB more profitable?

CGI Group has a net margin of 10.54% compared to Amdocs' net margin of 9.75%. Amdocs' return on equity of 20.28% beat CGI Group's return on equity. Company Net Margins Return on Equity Return on Assets Amdocs 9.75% 20.28% 10.94% CGI Group 10.54% 18.83% 9.83%

Does the media refer more to DOX or GIB?

In the previous week, CGI Group had 1 more articles in the media than Amdocs. MarketBeat recorded 4 mentions for CGI Group and 3 mentions for Amdocs. Amdocs' average media sentiment score of 0.97 beat CGI Group's score of 0.40 indicating that Amdocs is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Amdocs 2 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive CGI Group 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has preferable earnings & valuation, DOX or WIT?

Wipro has higher revenue and earnings than Amdocs. Wipro is trading at a lower price-to-earnings ratio than Amdocs, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Amdocs $4.53B 1.41 $564.70M $4.20 14.12 Wipro $9.87B 1.67 $1.41B $0.13 12.81

Is DOX or WIT more profitable?

Wipro has a net margin of 13.93% compared to Amdocs' net margin of 9.75%. Amdocs' return on equity of 20.28% beat Wipro's return on equity. Company Net Margins Return on Equity Return on Assets Amdocs 9.75% 20.28% 10.94% Wipro 13.93% 15.40% 9.67%

Amdocs (DOX) Competitors

$59.30 -1.21 (-2.00%)

Closing price 04:00 PM Eastern

Extended Trading

$59.30 +0.01 (+0.01%)

As of 07:30 PM Eastern

Compare

DOX vs. CTSH, SSNC, ACN, GIB, and WIT

Should you buy Amdocs stock or one of its competitors? Amdocs's main competitors and comparable companies include Cognizant Technology Solutions (CTSH), SS&C Technologies (SSNC), Accenture (ACN), CGI Group (GIB), and Wipro (WIT). Companies are selected based on similarities in market, industry, and size.

How does Amdocs compare to Cognizant Technology Solutions?

Amdocs (NASDAQ:DOX) and Cognizant Technology Solutions (NASDAQ:CTSH) are both technology companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, earnings, analyst recommendations, institutional ownership, dividends, risk, valuation and profitability.

Amdocs pays an annual dividend of $2.28 per share and has a dividend yield of 3.8%. Cognizant Technology Solutions pays an annual dividend of $1.32 per share and has a dividend yield of 2.2%. Amdocs pays out 54.3% of its earnings in the form of a dividend. Cognizant Technology Solutions pays out 28.4% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Amdocs has increased its dividend for 14 consecutive years and Cognizant Technology Solutions has increased its dividend for 6 consecutive years. Amdocs is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

92.0% of Amdocs shares are held by institutional investors. Comparatively, 92.4% of Cognizant Technology Solutions shares are held by institutional investors. 15.4% of Amdocs shares are held by insiders. Comparatively, 0.4% of Cognizant Technology Solutions shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Cognizant Technology Solutions has a net margin of 10.26% compared to Amdocs' net margin of 9.75%. Amdocs' return on equity of 20.28% beat Cognizant Technology Solutions' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Amdocs	9.75%	20.28%	10.94%
Cognizant Technology Solutions	10.26%	17.70%	12.81%

Amdocs has a beta of 0.42, indicating that its stock price is 58% less volatile than the broader market. Comparatively, Cognizant Technology Solutions has a beta of 0.83, indicating that its stock price is 17% less volatile than the broader market.

In the previous week, Cognizant Technology Solutions had 12 more articles in the media than Amdocs. MarketBeat recorded 15 mentions for Cognizant Technology Solutions and 3 mentions for Amdocs. Cognizant Technology Solutions' average media sentiment score of 1.13 beat Amdocs' score of 0.97 indicating that Cognizant Technology Solutions is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Amdocs	2 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Cognizant Technology Solutions	10 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Amdocs presently has a consensus target price of $86.67, indicating a potential upside of 46.15%. Cognizant Technology Solutions has a consensus target price of $63.65, indicating a potential upside of 6.32%. Given Amdocs' higher possible upside, research analysts plainly believe Amdocs is more favorable than Cognizant Technology Solutions.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Amdocs	1 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.29
Cognizant Technology Solutions	1 Sell rating(s)	13 Hold rating(s)	10 Buy rating(s)	0 Strong Buy rating(s)	2.38

Cognizant Technology Solutions has higher revenue and earnings than Amdocs. Cognizant Technology Solutions is trading at a lower price-to-earnings ratio than Amdocs, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Amdocs	$4.53B	1.41	$564.70M	$4.20	14.12
Cognizant Technology Solutions	$21.11B	1.28	$2.23B	$4.65	12.88

Summary

Cognizant Technology Solutions beats Amdocs on 12 of the 19 factors compared between the two stocks.

How does Amdocs compare to SS&C Technologies?

Amdocs (NASDAQ:DOX) and SS&C Technologies (NASDAQ:SSNC) are related companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, dividends, risk, profitability, institutional ownership, earnings, analyst recommendations and valuation.

Amdocs currently has a consensus target price of $86.67, indicating a potential upside of 46.15%. SS&C Technologies has a consensus target price of $92.63, indicating a potential upside of 15.88%. Given Amdocs' higher possible upside, analysts plainly believe Amdocs is more favorable than SS&C Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Amdocs	1 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.29
SS&C Technologies	0 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.80

SS&C Technologies has higher revenue and earnings than Amdocs. Amdocs is trading at a lower price-to-earnings ratio than SS&C Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Amdocs	$4.53B	1.41	$564.70M	$4.20	14.12
SS&C Technologies	$6.27B	2.99	$796.90M	$3.48	22.97

In the previous week, SS&C Technologies had 6 more articles in the media than Amdocs. MarketBeat recorded 9 mentions for SS&C Technologies and 3 mentions for Amdocs. Amdocs' average media sentiment score of 0.97 beat SS&C Technologies' score of 0.62 indicating that Amdocs is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Amdocs	2 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
SS&C Technologies	3 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

SS&C Technologies has a net margin of 13.16% compared to Amdocs' net margin of 9.75%. SS&C Technologies' return on equity of 21.20% beat Amdocs' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Amdocs	9.75%	20.28%	10.94%
SS&C Technologies	13.16%	21.20%	7.19%

Amdocs pays an annual dividend of $2.28 per share and has a dividend yield of 3.8%. SS&C Technologies pays an annual dividend of $1.20 per share and has a dividend yield of 1.5%. Amdocs pays out 54.3% of its earnings in the form of a dividend. SS&C Technologies pays out 34.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Amdocs has increased its dividend for 14 consecutive years and SS&C Technologies has increased its dividend for 9 consecutive years. Amdocs is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Amdocs has a beta of 0.42, suggesting that its stock price is 58% less volatile than the broader market. Comparatively, SS&C Technologies has a beta of 1.09, suggesting that its stock price is 9% more volatile than the broader market.

92.0% of Amdocs shares are held by institutional investors. Comparatively, 96.9% of SS&C Technologies shares are held by institutional investors. 15.4% of Amdocs shares are held by company insiders. Comparatively, 16.0% of SS&C Technologies shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

SS&C Technologies beats Amdocs on 14 of the 20 factors compared between the two stocks.

How does Amdocs compare to Accenture?

Amdocs (NASDAQ:DOX) and Accenture (NYSE:ACN) are both technology companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, media sentiment, dividends, valuation, analyst recommendations, institutional ownership, risk and profitability.

92.0% of Amdocs shares are held by institutional investors. Comparatively, 75.1% of Accenture shares are held by institutional investors. 15.4% of Amdocs shares are held by insiders. Comparatively, 0.0% of Accenture shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Amdocs has a beta of 0.42, suggesting that its share price is 58% less volatile than the broader market. Comparatively, Accenture has a beta of 1.1, suggesting that its share price is 10% more volatile than the broader market.

In the previous week, Accenture had 32 more articles in the media than Amdocs. MarketBeat recorded 35 mentions for Accenture and 3 mentions for Amdocs. Amdocs' average media sentiment score of 0.97 beat Accenture's score of 0.42 indicating that Amdocs is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Amdocs	2 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Accenture	9 Very Positive mention(s)	7 Positive mention(s)	14 Neutral mention(s)	4 Negative mention(s)	0 Very Negative mention(s)	Neutral

Amdocs pays an annual dividend of $2.28 per share and has a dividend yield of 3.8%. Accenture pays an annual dividend of $6.52 per share and has a dividend yield of 3.6%. Amdocs pays out 54.3% of its earnings in the form of a dividend. Accenture pays out 52.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Amdocs has raised its dividend for 14 consecutive years and Accenture has raised its dividend for 20 consecutive years.

Accenture has a net margin of 10.66% compared to Amdocs' net margin of 9.75%. Accenture's return on equity of 26.47% beat Amdocs' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Amdocs	9.75%	20.28%	10.94%
Accenture	10.66%	26.47%	12.89%

Amdocs currently has a consensus target price of $86.67, indicating a potential upside of 46.15%. Accenture has a consensus target price of $198.04, indicating a potential upside of 9.50%. Given Amdocs' higher possible upside, equities analysts clearly believe Amdocs is more favorable than Accenture.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Amdocs	1 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.29
Accenture	1 Sell rating(s)	16 Hold rating(s)	10 Buy rating(s)	0 Strong Buy rating(s)	2.33

Accenture has higher revenue and earnings than Amdocs. Amdocs is trading at a lower price-to-earnings ratio than Accenture, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Amdocs	$4.53B	1.41	$564.70M	$4.20	14.12
Accenture	$69.67B	1.73	$7.68B	$12.52	14.45

Summary

Accenture beats Amdocs on 14 of the 19 factors compared between the two stocks.

How does Amdocs compare to CGI Group?

Amdocs (NASDAQ:DOX) and CGI Group (NYSE:GIB) are both technology companies, but which is the better business? We will contrast the two companies based on the strength of their valuation, profitability, risk, media sentiment, analyst recommendations, dividends, earnings and institutional ownership.

Amdocs pays an annual dividend of $2.28 per share and has a dividend yield of 3.8%. CGI Group pays an annual dividend of $0.48 per share and has a dividend yield of 0.7%. Amdocs pays out 54.3% of its earnings in the form of a dividend. CGI Group pays out 8.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Amdocs has increased its dividend for 14 consecutive years. Amdocs is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

CGI Group has higher revenue and earnings than Amdocs. CGI Group is trading at a lower price-to-earnings ratio than Amdocs, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Amdocs	$4.53B	1.41	$564.70M	$4.20	14.12
CGI Group	$11.38B	1.26	$1.19B	$5.83	11.89

Amdocs has a beta of 0.42, suggesting that its share price is 58% less volatile than the broader market. Comparatively, CGI Group has a beta of 0.47, suggesting that its share price is 53% less volatile than the broader market.

Amdocs presently has a consensus price target of $86.67, indicating a potential upside of 46.15%. CGI Group has a consensus price target of $83.67, indicating a potential upside of 20.65%. Given Amdocs' stronger consensus rating and higher possible upside, research analysts clearly believe Amdocs is more favorable than CGI Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Amdocs	1 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.29
CGI Group	0 Sell rating(s)	7 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, CGI Group had 1 more articles in the media than Amdocs. MarketBeat recorded 4 mentions for CGI Group and 3 mentions for Amdocs. Amdocs' average media sentiment score of 0.97 beat CGI Group's score of 0.40 indicating that Amdocs is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Amdocs	2 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
CGI Group	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

CGI Group has a net margin of 10.54% compared to Amdocs' net margin of 9.75%. Amdocs' return on equity of 20.28% beat CGI Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Amdocs	9.75%	20.28%	10.94%
CGI Group	10.54%	18.83%	9.83%

92.0% of Amdocs shares are held by institutional investors. Comparatively, 66.7% of CGI Group shares are held by institutional investors. 15.4% of Amdocs shares are held by company insiders. Comparatively, 9.9% of CGI Group shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

Amdocs beats CGI Group on 12 of the 19 factors compared between the two stocks.

How does Amdocs compare to Wipro?

Amdocs (NASDAQ:DOX) and Wipro (NYSE:WIT) are both technology companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, risk, analyst recommendations, valuation, institutional ownership, profitability, media sentiment and earnings.

Wipro has higher revenue and earnings than Amdocs. Wipro is trading at a lower price-to-earnings ratio than Amdocs, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Amdocs	$4.53B	1.41	$564.70M	$4.20	14.12
Wipro	$9.87B	1.67	$1.41B	$0.13	12.81

92.0% of Amdocs shares are owned by institutional investors. Comparatively, 2.4% of Wipro shares are owned by institutional investors. 15.4% of Amdocs shares are owned by insiders. Comparatively, 1.0% of Wipro shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

In the previous week, Amdocs had 3 more articles in the media than Wipro. MarketBeat recorded 3 mentions for Amdocs and 0 mentions for Wipro. Amdocs' average media sentiment score of 0.97 beat Wipro's score of 0.62 indicating that Amdocs is being referred to more favorably in the media.

Company	Overall Sentiment
Amdocs	Positive
Wipro	Positive

Amdocs has a beta of 0.42, meaning that its stock price is 58% less volatile than the broader market. Comparatively, Wipro has a beta of 0.95, meaning that its stock price is 5% less volatile than the broader market.

Wipro has a net margin of 13.93% compared to Amdocs' net margin of 9.75%. Amdocs' return on equity of 20.28% beat Wipro's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Amdocs	9.75%	20.28%	10.94%
Wipro	13.93%	15.40%	9.67%

Amdocs currently has a consensus target price of $86.67, suggesting a potential upside of 46.15%. Wipro has a consensus target price of $1.70, suggesting a potential upside of 2.10%. Given Amdocs' stronger consensus rating and higher possible upside, analysts clearly believe Amdocs is more favorable than Wipro.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Amdocs	1 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.29
Wipro	3 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.25

Amdocs pays an annual dividend of $2.28 per share and has a dividend yield of 3.8%. Wipro pays an annual dividend of $0.04 per share and has a dividend yield of 2.4%. Amdocs pays out 54.3% of its earnings in the form of a dividend. Wipro pays out 30.8% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Amdocs has increased its dividend for 14 consecutive years. Amdocs is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Summary

Amdocs beats Wipro on 13 of the 19 factors compared between the two stocks.

Get Amdocs News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DOX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

DOX vs. The Competition

Export

Metric	Amdocs	IT Services Industry	Technology Sector	NASDAQ Exchange
Market Cap	$6.53B	$10.73B	$30.12B	$13.71B
Dividend Yield	3.76%	2.82%	2.75%	12.94%
P/E Ratio	14.12	13.78	77.05	25.39
Price / Sales	1.41	70.85	590.66	89.12
Price / Cash	7.72	45.66	48.01	51.66
Price / Book	1.93	8.17	7.80	6.33
Net Income	$564.70M	$271.17M	$704.48M	$358.24M
7 Day Performance	-3.45%	0.33%	-0.48%	1.20%
1 Month Performance	2.45%	-2.83%	-2.69%	-2.04%
1 Year Performance	-29.81%	21.16%	176.70%	5.41%

Amdocs Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
DOX Amdocs	4.8081 of 5 stars	$59.30 -2.0%	$86.67 +46.1%	-28.0%	$6.53B	$4.53B	14.12	26,969
CTSH Cognizant Technology Solutions	3.7435 of 5 stars	$58.32 +0.2%	$63.00 +8.0%	-11.6%	$26.27B	$21.11B	12.54	351,600	Positive News Analyst Forecast
SSNC SS&C Technologies	4.8194 of 5 stars	$78.92 -0.5%	$92.63 +17.4%	-9.9%	$18.52B	$6.56B	22.68	28,800
ACN Accenture	3.9475 of 5 stars	$177.79 +1.1%	$194.19 +9.2%	-21.1%	$118.73B	$69.67B	14.20	779,000	Trending News Analyst Forecast
GIB CGI Group	3.7163 of 5 stars	$69.11 +0.4%	$83.67 +21.1%	-23.0%	$14.31B	$11.38B	11.85	94,000	News Coverage Analyst Upgrade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:DOX) was last updated on 9/18/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Amdocs (DOX) Competitors

DOX vs. CTSH, SSNC, ACN, GIB, and WIT

How does Amdocs compare to Cognizant Technology Solutions?

Summary

How does Amdocs compare to SS&C Technologies?

Summary

How does Amdocs compare to Accenture?

Summary

How does Amdocs compare to CGI Group?

Summary

How does Amdocs compare to Wipro?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

DOX vs. The Competition

Amdocs Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Amdocs (DOX) Competitors

DOX vs. CTSH, SSNC, ACN, GIB, and WIT

How does Amdocs compare to Cognizant Technology Solutions?

Is DOX or CTSH a better dividend stock?

Do institutionals & insiders hold more shares of DOX or CTSH?

Is DOX or CTSH more profitable?

Which has more risk & volatility, DOX or CTSH?

Does the media prefer DOX or CTSH?

Do analysts prefer DOX or CTSH?

Which has stronger valuation & earnings, DOX or CTSH?

Summary

How does Amdocs compare to SS&C Technologies?

Do analysts recommend DOX or SSNC?

Which has preferable valuation and earnings, DOX or SSNC?

Does the media favor DOX or SSNC?

Is DOX or SSNC more profitable?

Is DOX or SSNC a better dividend stock?

Which has more volatility & risk, DOX or SSNC?

Do institutionals and insiders believe in DOX or SSNC?

Summary

How does Amdocs compare to Accenture?

Do insiders & institutionals have more ownership in DOX or ACN?

Which has more risk and volatility, DOX or ACN?

Does the media favor DOX or ACN?

Is DOX or ACN a better dividend stock?

Is DOX or ACN more profitable?

Do analysts rate DOX or ACN?

Which has preferable earnings & valuation, DOX or ACN?

Summary

How does Amdocs compare to CGI Group?

Is DOX or GIB a better dividend stock?

Which has higher earnings and valuation, DOX or GIB?

Which has more risk and volatility, DOX or GIB?

Do analysts prefer DOX or GIB?

Does the media refer more to DOX or GIB?

Is DOX or GIB more profitable?

Do insiders & institutionals believe in DOX or GIB?

Summary

How does Amdocs compare to Wipro?

Which has preferable earnings & valuation, DOX or WIT?

Do insiders & institutionals believe in DOX or WIT?

Does the media prefer DOX or WIT?

Which has more volatility & risk, DOX or WIT?

Is DOX or WIT more profitable?

Do analysts prefer DOX or WIT?

Is DOX or WIT a better dividend stock?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

DOX vs. The Competition

Amdocs Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools